Topotecan combined with Ifosfamide, Etoposide, and l-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma
Crossref DOI link: https://doi.org/10.1007/s12032-014-0402-0
Published Online: 2014-11-27
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shao, YaJuan
Guan, Mei
Chen, ShuChang
Jia, Ning
Wang, YuZhou
Text and Data Mining valid from 2014-11-27